← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lifegene-Biomarks, Inc.
San Juan, PR
$7,080,151
Total funding
4
Grants
Funding over time
peak $2.4M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,080,151 · 4
By mechanism
R44$5,347,659 · 3
R42$1,732,492 · 1
Investigators at Lifegene-Biomarks, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas$1,456,725
R42 · FY2025 · MD
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America$1,000,000
R44 · FY2023 · CA
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America$1,000,000
R44 · FY2022 · CA
Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings$912,858
R44 · FY2025 · CA
Precision methylation biomarkers linked to cancer disparities$802,513
R44 · FY2020 · MD
Precision methylation biomarkers linked to cancer disparities$733,762
R44 · FY2021 · MD
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America$399,998
R44 · FY2021 · CA
Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings$292,486
R44 · FY2023 · CA
Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas$275,767
R42 · FY2024 · MD
Precision methylation biomarkers linked to cancer disparities$206,042
R44 · FY2019 · MD